VIA
AHCO icon

Virtus Investment Advisers’s AdaptHealth AHCO Stock Holding History

Virtus Investment Advisers’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,800
Closed -$346K – 364
2024
Q3 		$346K Buy
+30,800
New +$327K 0.27% 117

Other funds holding AHCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Investment Advisers's AHCO Position: Q4 2024 in Review

Virtus Investment Advisers sold out of AdaptHealth (AHCO) in Q4 2024, closing a stake of 30,800 shares — an estimated $346K sold.

Virtus Investment Advisers first reported a position in AHCO in Q3 2024 and held it in 1 quarter. The position peaked at $346K in Q3 2024. 200 funds tracked by Wall St. Rank hold AHCO as of Q4 2024.

  • Virtus Investment Advisers reported no remaining AdaptHealth position as of Q4 2024 after selling out during the quarter.
  • Virtus Investment Advisers sold 30,800 AdaptHealth shares in Q4 2024, an estimated $346K.
  • Virtus Investment Advisers first reported a position in AdaptHealth in Q3 2024 and held it in 1 quarter.
  • Virtus Investment Advisers's AdaptHealth position peaked at $346K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2024.

Based on Virtus Investment Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.